Purpose. The management of loop diuretic resistance in the intensive care unit (ICU) is reviewed. Summary. Volume overload, a common complication of fluid resuscitation, is frequently encountered in ...

Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure (HF), yet torsemide has been shown to have less inter- and intra-individual variation in bioavailability ...

For patients with heart failure with reduced ejection fraction (HFrEF), treatment with sacubitril/valsartan may aid in reducing the requirement for loop diuretics compared with enalapril, according to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Increased exposure to loop diuretics ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — A treatment strategy of torsemide vs. furosemide did not improve long-term clinical outcomes for ...

CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...

At the third time of asking, Scpharmaceuticals Inc. has seen its subcutaneous loop diuretic, Furoscix (furosemide), approved by the U.S. FDA for patients with worsening heart failure, although the ...

Increasing loop diuretic dosages at discharge may reduce the rate of 30-day readmission for patients with acute decompensated heart failure (ADHF) with a low ejection fraction and evidence of fluid ...

prescription-medications-0416 SHPT risk was 4 times higher among patients taking furosemide vs hydrochlorothiazide. Non-dialysis chronic kidney disease (CKD) patients receiving loop diuretics may have ...

Edward Yu, professor of pharmacology at the School of Medicine, led a team of researchers in publication of an article titled “Inhibition mechanism of NKCC1 involves the carboxyl terminus and ...

What Is Enbumyst, and Why Does It Matter? Enbumyst is a new nasal spray form of bumetanide (first approved by the FDA in 1983). It is a type of medicine called a loop diuretic (also known as a “water ...